XML 29 R18.htm IDEA: XBRL DOCUMENT v3.25.2
REVENUE
 6 Months Ended
Jun. 30, 2025
Revenue from Contract with Customer [Abstract]  
REVENUE REVENUE
Revenue Recognition
Revenues are recognized when control of the promised goods is transferred to customers, in an amount that reflects the consideration the Company expects to realize in exchange for those goods.
The following table presents revenues disaggregated by revenue source. Sales and usage-based taxes are excluded from revenues.

Three Months Ended
June 30,		Six Months Ended
June 30,
2025202420252024
Product Sales Revenue$255,041 $233,726 $505,102 $472,852 
Royalty Revenue426 355 884 888 
Total Revenue$255,467 $234,081 $505,986 $473,740 

The following table presents revenues disaggregated by geography, based on customers' delivery addresses:

Three Months Ended
June 30,		Six Months Ended
June 30,
2025202420252024
United States$186,706 $177,692 $372,428 $359,778 
Foreign Countries68,761 56,389 133,558 113,962 
Total Revenue$255,467 $234,081 $505,986 $473,740 


Product Sales Revenues
The Company’s primary operation is the manufacturing and sale of health and nutrition ingredient products, in which the Company receives an order from a customer and fulfills that order. The Company’s product sales are considered point-in-time revenue.
Royalty Revenues
Royalty revenue consists of agreements with customers to use the Company’s intellectual property in exchange for a sales-based royalty. Royalties are considered over time revenue and are recorded in the Human Nutrition and Health segment.

Contract Liabilities
The Company records contract liabilities when cash payments are received or due in advance of performance, including amounts which are refundable.
The Company’s payment terms vary by the type and location of customers and the products offered. The term between invoicing and when payment is due is not significant. For certain products or services and customer types, the Company requires payment before the products are delivered to the customer.
Practical Expedients and Exemptions
The Company generally expenses sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling and marketing expenses.
The Company does not disclose the value of unsatisfied performance obligations for (i) contracts with an original expected length of one year or less and (ii) contracts for which the Company recognizes revenue at the amount to which it has the right to invoice for products shipped.